Hope abandoned: memantine therapy in frontotemporal dementia

Affiliations

Comment

John R Hodges. Lancet Neurol. 2013 Feb.

. 2013 Feb;12(2):121-3.

doi: 10.1016/S1474-4422(13)70001-2. Epub 2013 Jan 8.

¹ Neuroscience Research Australia and University of New South Wales, Randwick, NSW 2031, Australia. j.hodges@neura.edu.au

No abstract available

Comment on

Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial.
Boxer AL, Knopman DS, Kaufer DI, Grossman M, Onyike C, Graf-Radford N, Mendez M, Kerwin D, Lerner A, Wu CK, Koestler M, Shapira J, Sullivan K, Klepac K, Lipowski K, Ullah J, Fields S, Kramer JH, Merrilees J, Neuhaus J, Mesulam MM, Miller BL. Boxer AL, et al. Lancet Neurol. 2013 Feb;12(2):149-56. doi: 10.1016/S1474-4422(12)70320-4. Epub 2013 Jan 2. Lancet Neurol. 2013. PMID: 23290598 Free PMC article. Clinical Trial.